Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
  1. 4 Shares withheld for taxes Chief Accounting Officer gave up 170 shares (to pay taxes)
  2. 4 Gift EVP Chief Legal Officer gave 20,082 shares (gift)
  3. 4 Shares withheld for taxes Head of Research gave up 204 shares (to pay taxes)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Planned sale Head of Development sold 431 shares at $204.22 ($88,019)
  6. 4 Grant or award Director acquired 1,340 shares (grant or award)
  7. 4 Grant or award Director acquired 1,340 shares (grant or award)
  8. 4 Grant or award Director acquired 1,340 shares (grant or award)
  9. 4 Grant or award Director acquired 1,340 shares (grant or award)
  10. 4 Grant or award Director acquired 1,340 shares (grant or award)
  11. 4 Grant or award Director acquired 1,340 shares (grant or award)
  12. 4 Grant or award Director acquired 1,340 shares (grant or award)
  13. 4 Grant or award Director acquired 1,785 shares (grant or award)
  14. 4 Shares withheld for taxes Head of Corporate Development gave up 276 shares (to pay taxes)
  15. 4 Planned sale Head of Development sold 93 shares at $213.09 ($19,817)
  16. 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 117 shares (to pay taxes)
  17. 4 Planned sale Head of Development sold 262 shares at $221.23 ($57,962)
  18. 4 Shares withheld for taxes EVP Chief Legal Officer gave up 2,437 shares (to pay taxes)
  19. 4 Shares withheld for taxes EVP, Human Resources gave up 2,264 shares (to pay taxes)
  20. 4 Shares withheld for taxes Head of Global Product Strat. gave up 952 shares (to pay taxes)

Page 5 of 86 · 1,714 filings